(OPTZ) Optimize Strategy Index - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • • Mid-Cap Blend

OPTZ: Medium-Sized Companies, Balanced Investment Approach

Ticker Symbol: OPTZ | Exchange: NASDAQ | Type: ETF | Country Origin: USA | ETF Category: Mid-Cap Blend

The Optimize Strategy Index ETF (OPTZ) is a mid-cap blend ETF focused on U.S. equities. It seeks to provide exposure to mid-sized companies, blending both growth and value characteristics. The fund is designed to track the performance of its underlying index, which is optimized for specific investment criteria. Mid-cap blend ETFs typically invest in companies with market capitalizations between $2 billion and $10 billion, offering a balance between growth potential and stability compared to small- or large-cap equities.

Technical Data: Average Volume 20d: 4,000 shares | Last Price: $26.94 | SMA 20: $27.61 | SMA 50: $29.14 | SMA 200: $28.60 | ATR: 0.42

The ETF is currently trading below its 20-day and 50-day moving averages, indicating recent downward momentum. The 200-day moving average of $28.60 suggests a longer-term downtrend. The Average True Range (ATR) of 0.42 reflects low volatility, while the 20-day average volume of 4,000 shares indicates limited trading activity. These metrics suggest the ETF is in a consolidative phase with minimal directional movement.

Fundamental Data: AUM: $158.10 million

With assets under management (AUM) of $158.10 million, the ETF is a moderate-sized fund within its category. This level of AUM allows for efficient portfolio management while maintaining liquidity, though it may limit its ability to capitalize on smaller or more niche opportunities within the mid-cap space.

3-Month Forecast:

Technical Data: The ETF is likely to face resistance at its 50-day SMA ($29.14) and 200-day SMA ($28.60). Support levels may emerge near its recent lows, but the low ATR suggests limited upside potential. Expect a sideways to slightly bearish trend in the near term.

Fundamental Data: Mid-cap equities are sensitive to broader market conditions. If interest rates stabilize and economic growth shows signs of resilience, the ETF may experience modest inflows. However, with moderate AUM, it may lag larger, more liquid mid-cap ETFs in terms of performance.

Additional Sources for OPTZ ETF

OPTZ ETF Overview

Market Cap in USD 143m
Category Mid-Cap Blend
IPO / Inception 2024-04-22

OPTZ ETF Ratings

Growth Rating 12.3
Fundamental -
Dividend Rating 1.51
Rel. Strength -4.99
Analysts -
Fair Price Momentum 20.78 USD
Fair Price DCF -

OPTZ Dividends

Dividend Yield 12m 0.36%
Yield on Cost 5y 0.38%
Annual Growth 5y -100.00%
Payout Consistency 100.0%

OPTZ Growth Ratios

Growth Correlation 3m -91.1%
Growth Correlation 12m 51.7%
Growth Correlation 5y 51.7%
CAGR 5y -0.13%
CAGR/Max DD 5y -0.01
Sharpe Ratio 12m 1.01
Alpha -7.22
Beta 1.144
Volatility 44.48%
Current Volume 0.5k
Average Volume 20d 4.9k
What is the price of OPTZ stocks?
As of April 18, 2025, the stock is trading at USD 25.23 with a total of 465 shares traded.
Over the past week, the price has changed by +1.15%, over one month by -9.31%, over three months by -16.62% and over the past year by -0.13%.
Is Optimize Strategy Index a good stock to buy?
Neither. Based on ValueRay Analyses, Optimize Strategy Index is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 12.27 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OPTZ as of April 2025 is 20.78. This means that OPTZ is currently overvalued and has a potential downside of -17.64%.
Is OPTZ a buy, sell or hold?
Optimize Strategy Index has no consensus analysts rating.
What are the forecast for OPTZ stock price target?
According to ValueRays Forecast Model, OPTZ Optimize Strategy Index will be worth about 23.2 in April 2026. The stock is currently trading at 25.23. This means that the stock has a potential downside of -8.13%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 23.2 -8.1%